Logo-bi
BioImpacts. 2022;12(3): 291-292. doi: 10.34172/bi.2022.23266
PMID: 35677665        PMCID: PMC9124879

Perspective

SARS-CoV-2 and probable lung cancer risk

Sajad Khiali 1 ORCID, Afra Rezagholizadeh 1 ORCID, Taher Entezari-Maleki 1,2 * ORCID

Cited by CrossRef: 5




As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge